![Lori Kunkel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lori Kunkel
Directeur/Membre du Conseil chez
ORIC PHARMACEUTICALS, INC.
Fortune : 3 M $ au 31/07/2026
Profil
Lori Anne Kunkel is currently an Independent Director at Oric Pharmaceuticals, Inc. since 2020, K36 Therapeutics, Inc. since 2020, and Enliven Therapeutics, Inc. since 2024.
Dr. Kunkel is also the Owner of Lak505, LLC since 2012.
Former roles include Independent Director at Curis, Inc. from 2016 to 2022; Director at Tocagen, Inc. from 2019 to 2020; Director at Loxo Oncology, Inc. from 2013 to 2019; Director at Amphivena Therapeutics, Inc.; Director at Maverick Therapeutics, Inc. from 2015 to 2021; Independent Director at Nurix Therapeutics, Inc. from 2019 to 2025; Director at Harpoon Therapeutics, Inc. from 2015 to 2016; Associate Director-Clinical Development at Chiron Corp.
from 1997 to 1998; Head-Clinical Scientist at Genentech, Inc. from 1998 to 2000; Chief Medical Officer at Pharmacyclics LLC from 2011 to 2013; Vice President-Medical Affairs at Genitope Corp.
from 2000 to 2003; Vice President-Clinical Development at Xencor, Inc. from 2005 to 2007; Chief Medical Officer at Syndax Pharmaceuticals, Inc. from 2009 to 2011; Chief Medical Officer at Proteolix, Inc. from 2007 to 2009; Chief Medical Officer at ACT Biotech, Inc. from 2010 to 2011; and Principal roles at Onyx Pharmaceuticals, Inc., XOMA Royalty Corp., ZymoGenetics, Inc., Salmedix, Inc., and DNAX Research, Inc. Dr. Kunkel was a Member of the Bone Marrow Transplant Unit at the University of California.
Education includes a doctorate from the University of Southern California and an undergraduate degree from the University of California San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/07/2026 | 41 884 ( 0,06 % ) | 2 M $ | 31/07/2026 | |
| 31/03/2026 | 84 200 ( 0,08 % ) | 932 094 $ | 31/07/2026 | |
| 19/05/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Lori Kunkel
| Sociétés | Poste | Début |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/06/2020 |
| ENLIVEN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 09/04/2024 |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Directeur/Membre du Conseil | 01/06/2020 |
Lak505, LLC | Corporate Officer/Principal | 01/04/2012 |
Anciens postes connus de Lori Kunkel
| Sociétés | Poste | Fin |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2025 |
| CURIS, INC. | Directeur/Membre du Conseil | 30/09/2022 |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Directeur/Membre du Conseil | 01/08/2021 |
| FORTE BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 15/04/2019 |
| LOXO ONCOLOGY INC | Directeur Technique/Scientifique/R&D | 01/08/2013 |
Formation de Lori Kunkel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Develops immunotherapies for the treatment of cancer | Health Technology |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology and small molecule drugs to treat hematologic malignancies | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Develops biopharmaceutical drugs | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
DNAX Research, Inc. | |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs | Health Technology |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Health Technology |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
Lak505, LLC | |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Health Technology |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
